BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 83 filers reported holding BICYCLE THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $227,117 | -29.4% | 11,305 | -10.4% | 0.00% | – |
| Q2 2023 | $321,858 | +8.9% | 12,612 | -9.2% | 0.00% | – |
| Q1 2023 | $295,483 | -22.9% | 13,892 | +7.3% | 0.00% | – |
| Q4 2022 | $383,084 | -42.1% | 12,942 | -54.5% | 0.00% | – |
| Q3 2022 | $662,000 | +203.7% | 28,475 | +119.6% | 0.00% | – |
| Q2 2022 | $218,000 | -44.0% | 12,966 | +45.9% | 0.00% | – |
| Q1 2022 | $389,000 | +620.4% | 8,884 | +896.0% | 0.00% | – |
| Q4 2021 | $54,000 | +54.3% | 892 | +5.4% | 0.00% | – |
| Q3 2021 | $35,000 | -32.7% | 846 | -50.7% | 0.00% | – |
| Q2 2021 | $52,000 | +372.7% | 1,715 | +387.2% | 0.00% | – |
| Q1 2021 | $11,000 | +175.0% | 352 | +50.4% | 0.00% | – |
| Q4 2020 | $4,000 | -55.6% | 234 | -52.7% | 0.00% | – |
| Q3 2020 | $9,000 | -75.0% | 495 | -78.3% | 0.00% | – |
| Q2 2020 | $36,000 | +111.8% | 2,285 | +33.0% | 0.00% | – |
| Q2 2019 | $17,000 | – | 1,718 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 917,218 | $40,248,000 | 48.61% |
| GREAT POINT PARTNERS LLC | 550,592 | $24,160,000 | 5.84% |
| Logos Global Management LP | 950,000 | $41,686,000 | 5.40% |
| Deep Track Capital, LP | 1,855,993 | $81,441,000 | 5.22% |
| First Light Asset Management, LLC | 890,174 | $39,061,000 | 3.44% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,154,126 | $50,643,000 | 3.00% |
| Ikarian Capital, LLC | 478,784 | $21,009,000 | 2.76% |
| Opaleye Management Inc. | 175,000 | $7,679,000 | 2.38% |
| Frazier Life Sciences Management, L.P. | 603,521 | $26,483,000 | 2.26% |
| Altium Capital Management LP | 120,000 | $5,266,000 | 1.76% |